Mr. Berman concluded, ''DECN is now shifting into a higher gear. Our GenChoice! test strip is in review and we have high hopes for its success; our first large private label agreement is advancing; and, we are now pivoting to the GenUltimate! 4Pets launch in the next two weeks. In fact the ''G 4Pets'' product has been assigned a February manufacturing slot. We are also very excited about the beginning of the scheduled clinical trials for our GenUltimate! TBG.''
Love this part.
(0)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links